HARVARD BIOSCIENCE INC
For the period ended Jun 30, 2025. Filed Aug 11, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 11, 2025
HBIO$9.26+1.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Loss
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| Net loss | $(2,282) | $(2,927) | $(52,622) | $(7,621) |
| Other comprehensive income (loss), net of tax: | ||||
| Foreign currency translation adjustments | 2,622 | (128) | 3,914 | (911) |
| Derivative instruments qualifying as cash flow hedges, net of tax of $-0- | 37 | 34 | 54 | 233 |
| Other comprehensive income (loss) | 2,659 | (94) | 3,968 | (678) |
| Comprehensive income (loss) | $377 | $(3,021) | $(48,654) | $(8,299) |
**CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.